Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
cytokine release syndrome
MeSH D000080424 - cytokine release syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018746:
Systemic inflammatory response syndrome
0 Companies
0 Drugs
Success rate
D000080424:
Cytokine release syndrome
2 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Fresenius Kabi
Tocilizumab
Tyenne
2023-09-15
Roche
Tocilizumab
RoActemra
2009-01-15
Clinical Trials
Historical Success Rate
Phase 1
50
%
1/2
Phase 2
42
%
8/19
Phase 3
33
%
2/6
Approved:
1
Overall Success rate:
7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Fresenius Kabi
Tocilizumab
Roche
Tocilizumab
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use